Balance Sheet

v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2025
Jun. 30, 2024
Current assets    
Cash $ 230,392 $ 661,415
Accounts receivable, net 180,897 606,885
Inventory, net 1,324,540 1,431,556
Due from VitaMedica transition 0 212,358
Prepaid expenses and other receivables 232,328 502,188
Assets available for sale - Building 0 4,005,516
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Purchase price receivable - E-core 0 2,000,000
Total current assets 3,968,157 11,419,918
Property and equipment, net 1,972,522 2,356,556
Intangible assets, net 182,300 239,871
Goodwill 848,854 848,854
Deferred tax asset 5,948,858 5,948,858
Digital assets 44,732 0
Other assets 192,122 278,435
Right-of-use asset, net 1,909,769 2,418,596
Total other assets 11,099,157 12,091,170
Total assets 15,067,314 23,511,088
Current liabilities    
Accounts payable 1,414,929 481,647
Accrued compensation 1,098,146 1,098,856
Deferred revenue 23,914 235,255
Accrued liabilities 223,535 736,407
Accrued interest 834,056 476,018
Acquisition payable 260,652 413,152
Related party advances, net 75,000 100,000
Current portion of note payable 420,000 0
Current portion of convertible notes payable 525,000 0
Current portion of related party note payable 375,000 0
Current portion of Cygnet subsidiary notes payable 5,380,909 5,447,565
Note payable on building for sale 0 2,634,538
Current portion of operating lease payable 165,060 1,031,714
Total current liabilities 10,796,201 12,655,152
Operating lease payable, net of current portion 1,844,233 1,732,606
Related party note payable 125,000 500,000
Note payable 140,000 557,429
Convertible notes payable 311,170 1,550,000
Total long-term liabilities 2,420,403 4,340,035
Stockholders' equity    
Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 25,000 and 25,000 shares issued and outstanding, respectively 150 25
Common stock, $0.001 par value, 100,000,000 shares authorized, and 1,430,429 and 1,045,429 shares issued and outstanding, respectively 1,430 1,045
Additional paid in capital 55,467,290 53,374,444
Accumulated deficit (53,618,160) (46,859,613)
Total stockholders' equity attributable to Upexi, Inc. 1,850,710 6,515,901
Total stockholders' equity 1,850,710 6,515,901
Total liabilities and stockholders' equity $ 15,067,314 $ 23,511,088

Source

PDF HTML
ZIP